# Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate

> **NCT00472563** · PHASE2,PHASE3 · COMPLETED · sponsor: **Universidad de Antioquia** · enrollment: 212 (actual)

## Conditions studied

- Acute Kidney Failure

## Interventions

- **DRUG:** Bicarbinate 150 mEq/L

## Key facts

- **NCT ID:** NCT00472563
- **Lead sponsor:** Universidad de Antioquia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2008-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00472563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00472563, "Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00472563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*